Cervical cancer: Treatment challenges in the developing world

Radiotherapy and Oncology

Volumn 79, Issue 2, 2006, Pages 139-141

  Thomas, Gillian ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BEAM THERAPY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; COBALT TELETHERAPY; EDITORIAL; HEALTH CARE ACCESS; HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

DEVELOPING COUNTRIES; FEMALE; HEALTH RESOURCES; HUMANS; INDIA; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 33744996056     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.03.019     Document Type: Editorial

References (18)

1. Allt W.E. Supervoltage radiation treatment in advanced cancer of the uterine cervix. Can Med Assoc J 100 (1969) 792-797
2. Cosbie W.G. The contribution of radiotherapy to the modern treatment of female pelvic cancer. Obstet Gynecol 66 (1959) 843-848
3. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
4. Ferlay J., Bray F., Pisani P., and Parkin D.M. Cancer incidence, mortality and prevalence worldwide. GLOBOCAN (2002)
5. Levin C.V., El Gueddari B., and Meghzifene A. Radiation therapy in Africa: distribution and equipment. Radiother Oncol 52 (1999) 79-84
6. Levin C.V., and Tatsuzaki H. Radiotherapy services in transition: gross national income per capita as a significant factor. Radiother Oncol 63 (2002) 147-150
7. Logsdon M., and Eifel P.J. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 43 (1999) 763-775
8. Mell L.K., Mehrotra A.K., and Mundt A.J. Intensity-modulated radiation therapy use in the US, 2004. Cancer 104 (2005) 1296-1303
9. Mell L.K., Roeske J.C., and Mundt A.J. A survey of intensity-modulated radiation therapy use in the United States. Cancer 98 (2003) 204-211
10. Paterson R, Tod M, Russell M. Result of radium and x-ray therapy in malignant disease, second statistical report from the Holt Radium Institute, Manchester, 1934-38, England.
11. Richards G.E. The radiological treatment of carcinoma cervix uteri. Proc R Soc Med 40 (1947) 911-917
12. Saibishkumar EP, Patel FD, Sharma SC, et al. Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: A retrospective analysis of 556 patients from India. Radiother Oncol 2006;79:145-49.
13. Salminen E., Izewska J., and Andreo P. IAEA's role in the global management of cancer-focus on upgrading radiotherapy services. Acta Oncol 44 (2005) 816-824
14. Sigurdsson K. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995. Acta Obstet Gynecol Scand 78 (1999) 478-485
15. Tatsuzaki H., and Levin C.V. Quantitative status of resources for radiation therapy in Asia and Pacific region. Radiother Oncol 60 (2001) 81-89
16. Thomas G.M. Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. N Eng J Med 340 (1999) 1198-1200 [Editorial; Comment]
17. Trimble E.L., Harlan L.C., and Clegg L.X. Untreated cervical cancer in the United States. Gynecol Oncol 96 (2005) 271-277
18. Van der Giessen P.H., Alert J., Badri C., et al. Multinational assessment of some operational costs of teletherapy. Radiother Oncol 71 (2004) 347-355